AstraZeneca PLC (AZN)
185.71
-1.48
(-0.79%)
USD |
NYSE |
May 27, 16:00
185.28
-0.43
(-0.23%)
After-Hours: 20:00
AstraZeneca EPS Diluted (Quarterly) : 0.9849 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| GSK Plc | 1.149 |
| Johnson & Johnson | 2.141 |
| Eli Lilly & Co. | 8.255 |
| Merck & Co., Inc. | -1.715 |
| Novo Nordisk A/S | 1.709 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.076B |
| Revenue (Quarterly) | 15.26B |
| Total Expenses (Quarterly) | 12.19B |
| Enterprise Value | 316.59B |
| Gross Profit Margin (Quarterly) | 76.09% |
| Profit Margin (Quarterly) | 20.15% |
| Earnings Yield | 1.79% |
| Operating Earnings Yield | 2.42% |
| Normalized Earnings Yield | 1.814 |